TherapeuticsMD, Inc. (TXMD) Financials

TXMD Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 50.5 million 22.4 million
2023-06-30 53.7 million 22.5 million
2023-03-31 90.5 million 55.3 million
2022-12-31 809040 49186

TXMD Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -6.0 million 234000
2023-06-30 -3.4 million 438000
2023-03-31 59.7 million 3.0 million
2022-12-31 30706 3.0 million

TXMD Net Income

No data available :(

TXMD Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 10.2 million - 8.2 million
2023-06-30 13.7 million - 8.4 million
2023-03-31 38.1 million - 8.6 million
2022-12-31 363148 - 8.8 million

TXMD Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 10.7 million
2023-06-30 10.2 million
2023-03-31 9.4 million
2022-12-31 16982

TXMD Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - - 1.6 million -
2023-06-30 10000 - 2.8 million -
2023-03-31 37000 4.1 million 2.5 million 61.7 million
2022-12-31 10000 4.1 million 59.2 million -

TXMD Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 -53000 130000
2023-06-30 437000 128000
2023-03-31 1.2 million 3.4 million
2022-12-31 103108 29735

TXMD

Price: $1.88

52 week price:
1.86
4.72

Earnings Per Share: 4.85 USD

P/E Ratio: 0.46

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 688

Ebitda: -21.6 million

Market Capitalization: 22.3 million

Links: